KORU Medical Systems (KRMD) Cash from Financing Activities (2010 - 2026)
KORU Medical Systems (KRMD) recorded quarterly Cash from Financing Activities of -$29216.0 in Q1 2026, up 88.97% quarter-over-quarter from -$264908.0 in Q4 2025, and up 81.83% on a YoY basis from -$16067.6 in Q1 2025.
KORU Medical Systems (KRMD) Cash from Financing Activities (2010 - 2026) Analysis & Trends
KORU Medical Systems' Cash from Financing Activities history runs 11 years deep, the most recent figure standing at -$29216.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 81.83% year-over-year to -$29216.0; the TTM figure through Mar 2026 stood at -$89758.0 (up 60.5% YoY), while the FY2025 annual figure was -$221350.0, up 10.94% from the prior year.
- Cash from Financing Activities was -$29216.0 for Q1 2026 at KORU Medical Systems, up from -$264908.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $940282.0 in Q3 2022 to a low of -$264908.0 in Q4 2025.
- Historically, Cash from Financing Activities has averaged -$25793.0 across 5 years, with a median of -$182120.0 in 2024.
- The sharpest annual moves came in 2022 and 2026: Cash from Financing Activities slumped 32154.12% in 2022, then surged 81.83% in 2026.
- A 5-year view of Cash from Financing Activities shows it stood at -$145603.0 in 2022, then declined by 22.49% to -$178355.0 in 2023, then declined by 20.95% to -$215716.0 in 2024, then fell by 22.8% to -$264908.0 in 2025, then soared by 88.97% to -$29216.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$29216.0 (Q1 2026), -$264908.0 (Q4 2025), and $396330.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -13.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -255.24 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -308.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -50.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -48.13 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 Mn |
| 10 | KORU Medical Systems | 183.37 Mn | 174.57 Mn | 7.23 Mn | -29,216.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29,216.00 |
| Mar 31, 2026 | -29,216.00 |
| Dec 31, 2025 | -264,908.00 |
| Dec 31, 2025 | -264,908.00 |
| Sep 30, 2025 | 396,330.00 |
| Sep 30, 2025 | 396,330.00 |
| Jun 30, 2025 | -191,964.00 |
| Jun 30, 2025 | -191,964.00 |
| Mar 31, 2025 | -160,808.00 |
| Mar 31, 2025 | -160,808.00 |
| Dec 31, 2024 | -215,716.00 |
| Dec 31, 2024 | -215,716.00 |
| Sep 30, 2024 | 374,454.00 |
| Sep 30, 2024 | 374,454.00 |
| Jun 30, 2024 | -225,151.00 |
| Jun 30, 2024 | -225,151.00 |
| Mar 31, 2024 | -182,120.00 |
| Mar 31, 2024 | -182,120.00 |
| Dec 31, 2023 | -178,355.00 |
| Dec 31, 2023 | -178,355.00 |